Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both
Citation
pfeffer , P , Ali , N , Murray , R , Ulrik , C , Tran , T , Maspero , J , Peters , M , Christoff , G , Sadatsafavi , M , Torres-Duque , C A , Altraja , A , Lehtimäki , L , Papadopoulos , N , Salvi , S , Costello , R W , Cushen , B , Heffler , E , Iwanaga , T , Al-Ahmad , M , Larenas-Linnemann , D , Kuna , P , Fonseca , J , Al-Lehebi , R , Rhee , C K , Llano , L P D , Perng , D-W , Mahboub , B , Wang , E , Goh , Y Y C , Lyu , J , Newell , A , Alacqua , M , Bhutani , M , Bjermer , L , Björnsdóttir , U S , Bourdin , A , Bülow , A V , Busby , J , Canonica , W , Cosio , B G , Dorscheid , D , Esquerre , M M , FitzGerald , M , Gil , E G , Gibson , P G , Heaney , L , Hew , M , Hilberg , O , Hoyte , F , Jackson , D , Koh , M , Ko , H-K , Lee , J H , Lehmann , S , Loureiro , C C , Ludviksdottir , D , Menzies-Gow , A , Mitchell , P , Papaioannou , A , Popov , T , Porsbjerg , C , Salameh , L , Sirena , C , Taillé , C , Taube , C , Tohda , Y , Wechsler , M E & Price , D 2023 , ' Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in severe asthma patients eligible for both ' , Allergy . https://doi.org/10.22541/au.166563547.79282253/v1 , https://doi.org/10.1111/all.15711
Rights
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. © 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.